Surgery and radiotherapy in vulvar cancer

Critical Reviews in Oncology/Hematology

Volumn 60, Issue 1, 2006, Pages 38-58

  de Hullu, J A ^b   van der Zee, A G J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Advanced disease; Radiotherapy; Sentinel lymph node; Surgery; Vulvar cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; MITOMYCIN C;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHEDEMA; MULTIMODALITY CANCER THERAPY; NEPHROTOXICITY; NEUROTOXICITY; OTOTOXICITY; POSTOPERATIVE COMPLICATION; PSYCHOSEXUAL DISORDER; REVIEW; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; URINE INCONTINENCE; VULVA CANCER; VULVECTOMY;

CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MODELS, BIOLOGICAL; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; SENTINEL LYMPH NODE BIOPSY; VULVAR NEOPLASMS;

EID: 33748296161     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2006.02.008     Document Type: Review

References (156)

1. Hacker N.F. Vulvar cancer. In: Berek J.S., and Hacker N.F. (Eds). Practical gynecologic oncology. 4th ed. (2005), Williams & Wilkins, Philadelphia 585-602
2. Visser O., Coebergh J.W.W., and Schouten L.J. Incidence of cancer in the Netherlands 1993 (1996), Hoonte-Holland BV, Utrecht
3. Coulter J., and Gleeson N. Local and regional recurrences of vulval cancer: management dilemmas. Best Pract Res Clin Obstet Gynaecol 17 (2003) 663-681
4. Podratz K.C., Symmonds R.E., Taylor W.F., and Williams T.J. Carcinoma of the vulva: analysis of treatment and survival. Obstet Gynecol 61 (1983) 63-74
5. Rosen C., and Malmström H. Invasive cancer of the vulva. Gynecol Oncol 65 (1997) 213-217
6. Rutledge F., Smith J.P., and Franklin E.W. Carcinoma of the vulva. Am J Obstet Gynecol 106 (1970) 1117-1130
7. Finan M.A., and Barre G. Bartholin's gland carcinoma, malignant melanoma and other rare tumours of the vulva. Best Pract Res Clin Obstet Gynaecol 17 (2003) 609-633
8. Shepherd J.H. Staging announcement. FIGO staging of gynecologic cancers; cervical and vulva. Int J Gynecol Cancer 5 (1995) 319
9. Homesley H.D., Bundy B.N., Sedlis A., et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (A Gynecologic Oncology Group Study). Am J Obstet 164 (1991) 997-1004
10. Taussig F.J. Cancer of the vulva: an analysis of 155 cases. Am J Obstet Gynecol 40 (1940) 764-779
11. Way S. Carcinoma of the vulva. Am J Obstet Gynecol 79 (1960) 692-697
12. Gotlieb. The assessment and surgical management of early-stage vulvar cancer. Best Pract Res Clin Obstet Gynaecol 17 (2003) 557-569
13. Andersen B.L., and Hacker N.F. Psychosexual adjustment after vulvar surgery. Obstet Gynecol 62 (1983) 457-462
14. Curry S.L., Wharton J.T., and Rutledge F. Positive lymph nodes in vulvar squamous carcinoma. Gynecol Oncol 9 (1980) 63-67
15. Hacker N.F., Berek J.S., Lagasse L.D., et al. Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol 61 (1983) 408-412
16. Homesley H.D., Bundy B.N., Sedlis A., and Adcock L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 68 (1986) 733-740
17. Iversen T., and Aas M. Lymph drainage from the vulva. Gynecol Oncol 16 (1983) 179-189
18. Burger M.P.M., Hollema H., and Bouma J. The side of groin node metastases in unilateral vulvar carcinoma. Int J Gynecol Cancer 6 (1996) 318-322
19. van der Velden J. Some aspects of the management of squamous cell carcinoma of the vulva. Thesis. Amsterdam, The Netherlands; 1996.
20. Stehman F.B., Bundy B.N., Dvoretsky P.M., and Creasman W.T. Early stage I carcinoma of the vulva treated with ipsilateral superficial lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol 79 (1992) 490-497
21. Byron S.C., Lamb E.J., Yonemoto R.H., and Kase S. Radical inguinal node dissection in the treatment of cancer. Surg Gynecol Obstet 114 (1962) 401-408
22. Willis R.A. The spread of tumors in the human body. 3rd ed. (1973), Butterworth, London p. 19-30
23. Hacker N.F., Leuchter R.S., Berek J.S., Castaldo T.W., and Lagasse L.D. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol 58 (1981) 574-579
24. Schulz M.J., and Penalver M. Recurrent vulvar carcinoma in the intervening tissue bridge in early invasive stage I disease treated by radical vulvectomy and bilateral groin dissection through separate incisions. Gynecol Oncol 35 (1989) 383-386
25. Grimshaw R.N., Murdoch J.B., and Monaghan J.M. Radical vulvectomy and bilateral inguinal-femoral lymphadenectomy through separate incisions-experience with 100 cases. Int J Gynecol Cancer 3 (1993) 18-23
26. Christopherson W., Buchsbaum H.J., Voet R., and Lifschitz S. Radical vulvectomy and bilateral groin lymphadenectomy utilizing separate groin incisions: report of a case with recurrence in the intervening skin bridge. Gynecol Oncol 21 (1985) 247-251
27. Rose P.G. Skin bridge recurrences in vulvar cancer: frequency and management. Int J Gynecol Cancer 9 (1999) 508-511
28. Hopkins M.P., Reid G.C., and Morley G.W. Radical vulvectomy. The decision for the incision. Cancer 72 (1993) 799-803
29. Ansink A., and van der Velden J. Surgical interventions for early squamous cell carcinoma of the vulva (Cochrane Review). Cochrane library, issue 1 (2002), Update Software, Oxford
30. de Hullu J.A., Hollema H., Lolkema S., et al. Vulvar carcinoma. The price of less radical surgery. Cancer 95 (2002) 2331-2338
31. Burger M.P., Hollema H., Emanuels A.G., et al. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol 57 (1995) 327-334
32. Arvas M., Rose F., Gezer A., Demirkiran F., Tulunay G., and Kosebay D. Radical versus conservative surgery for vulvar carcinoma. Int J Gynecol Obstet 88 (2005) 127-133
33. Hyde W.E., Valmader S., Hacker N.F., Schilthuis M.S., and van der Velden J. Nodal debulking instead of full groin dissection results in similar survival in patinets with clinical suspicious groin nodes and squamous cell cancer of the vulva. Int J Gyn Cancer (2004) [abstract 290 IGCS meeting Edinbrough]
34. Burke T.W., Levenback C., Coleman R.L., et al. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol 57 (1995) 215-220
35. 0) disease. Gynecol Oncol 53 (1994) 55-58
36. Heaps J.M., Fu Y.S., Montz F.J., et al. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 38 (1990) 309-314
37. de Hullu J.A., and van der Zee A.G.J. Groin surgery and the sentinel lymph node. Best Pract Res Clin Obstet Gynaecol 17 (2003) 571-589
38. Lin J.Y., DuBeshter B., Angel C., and Dvoretsky P.M. Morbidity and recurrecne with modifications of radical vulvectomy and groin dissection. Gynecol Oncol 47 (1992) 80-86
39. Paley P.J., Johnson P.R., Adcock L.L., et al. The effect of sartorius transposition on wound morbidity following inguinal-femoral lymphadenectomy. Gynecol Oncol 64 (1997) 237-241
40. Rouzier R., Haddad B., Dubernad G., Dubois P., and Paniel B. Inguinofemoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival. J Am Coll Surg 196 (2003) 442-450
41. Zhang S.H., Sood A.K., Sorosky J.I., Anderson B., and Buller R.E. Preservation of the saphenous vein during inguinal lymphadenectomy decreases morbidity in patients with carcinoma of the vulva. Cancer 89 (2000) 1520-1525
42. Micheletti L., Borgno G., Barbero M., et al. Deep femoral lymphadenectomy with preservation of the fascial lata. J Reprod Med 35 (1990) 1130-1133
43. Borgno G., Micheletti L., Barbero M., et al. Topographic distribution of groin lymph nodes; a study of 50 female cadavers. J Reprod Med 35 (1990) 1127-1129
44. Judson P.L., Jonson A.L., Paley P.J., et al. A prospective, randomized study analyzing sartorius transposition following inguinal-femoral lymphadenectomy. Gynecol Oncol 95 (2004) 226-230
45. Levenback C., Morris M., Burke T.W., et al. Groin dissection practices among gynecologic oncologists treating early vulvar cancer. Gynecol Oncol 62 (1996) 73-77
46. Gibson S.C., Kettlewell S., Byrne D.S., McKay A.J., et al. Surgical management of metastatic inguinal lymphadenopathy. BMJ 330 (2005) 538-539
47. Barton D.P. The prevention and management of treatment related morbidity in vulval cancer. Best Pract Res Clin Obstet Gynaecol 17 (2003) 683-701
48. Weijmar Schultz W.C., van de Wiel H.B., Bouma J., Janssens J., and Littlew J. Psychosexual functioning after the treatment of cancer of the vulva. A longitudinal study. Cancer 15 (1990) 402-407
49. Janda M., Obermair A., Cella D., et al. The functional assessment of cancer-vulvar: reliability and validity. Gynecol Oncol 97 (2005) 568-575
50. Cella D.J., Tulsky D.S., Gray G., et al. The functional assessment of cancet therapy scale: development and validation of the general measure. J Clin Oncol 11 (1993) 570-579
51. Gaarenstroom K.N., Kenter G.G., Trimbos J.B., et al. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Oncol 13 (2003) 22-27
52. Gould N., Kamelle S., Tillmanns T., et al. Predictors of complications after inguinal lymphadenectomy. Gynecol Oncol 82 (2001) 329-332
53. Helm C.W., Hatch K., Austin J.M., et al. A matched comparison of single and triple incision techniques for the surgical treatment of carcinoma of the vulva. Gynecol Oncol 46 (1992) 150-156
54. Pereira de Godoy J.M., Braile D.M., de Fatima Godoy M., and Longo Jr. O. Quality of life and peripheral lymphedema. Lymphology 3 (2002) 72-75
55. Coit D.G., Peters M., and Brennan M.F. A prospective randomized trial of perioperative cefazolin treatment in axillary and groin dissection. Arch Surg 12 (1991) 1366-1371
56. Selman T.J., Luesley D.M., Acheson N., Khan K.S., and Mann C.H. A systematic review of the accuracy of diagnostic tests for inguinal lymph node status in vulvar cancer. Gynecol Oncol 99 (2005) 206-214
57. Oonk MHM, Hollema H, de Hullu JA, van der Zee AGJ. Prediction of lymph node metastases in vulvar cancer, a review. Int J Gynecol Oncol 2006; in press.
58. Mäkelä P.J., Leminen A., Kääriäinen M., and Lehtovirta P. Pretreatment sonographic evaluation of inguinal lymph nodes in patients with vulvar malignancy. J Ultrasound Med 5 (1993) 255-258
59. Abang Mohammed D.K., Uberoi R., de B Lopes A., and Monaghan J.M. Inguinal node status by ultrasound in vulvar cancer. Gynecol Oncol 77 (2000) 93-96
60. Cohn D.E., Dehdashti F., Gibb R.K., et al. Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. Gynecol Oncol 85 (2002) 179-184
61. Sohaib S.A., Richards P.S., Ind T., et al. MR imaging of carcinoma of the vulva. Am J Roentgenol 178 (2002) 373-377
62. Bellin M.F., Roy C., Kinkel K., et al. Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles-initial clinical experience. Radiology 207 (1998) 799-808
63. Sohaib S.A., and Moskovic E.C. Imaging in vulval cancer. Best Pract Res Clin Obstet Gynaecol 17 (2003) 543-556
64. Moskovic E.C., Shepherd J.H., Barton D.J., et al. The role of high resolution ultrasound with guided cytology of groin lymph nodes in the management of squamous cell carcinoma of the vulva: a pilot study. Br J Obstet Gynaecol 106 (1999) 863-867
65. Cabanas R.M. An approach for the treatment of penile cancer. Cancer 39 (1977) 456-466
66. Morton D.L., Wen D.R., Wong J.H., et al. Technical details of intraoperative lymphatic mapping for early-stage melanoma 127 (1992) 392-399
67. Kapteijn BAE. Biopsy of the sentinel node in melanoma, penile carcinoma and breast carcinoma. The case for lymphatic mapping. Thesis. Amsterdam, The Netherlands; 1997.
68. Krag D.N., Meijer S.J., Weaver D.L., et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 130 (1995) 654-658
69. Albertini J.J., Lyman G.H., Cox C., et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276 (1996) 1818-1822
70. Gershenwald J.E., Colome M.I., Lee J.E., et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 16 (1998) 2253-2260
71. Roumen R.M., Kuijt G.P., Liem I.H., and van Beek M.W. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg 88 (2001) 1639-1643
72. Cody III H.S. Current surgical management of breast cancer. Curr Opin Obstet Gynecol 14 (2002) 45-52
73. Thompson J.F., Scoluer R.A., and Kefford R.F. Cutaneous melanoma. Lancet 365 (2005) 687-701
74. Morton D.L., Cochran A.J., Thomspon J.F., et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 242 (2005) 302-311
75. Estourgie S.H., Hieweg O.E., and Kroon B.B.R. High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma. Br J Surg 91 (2004) 1370-1371
76. Thomas J.M., and Clark M.A. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma. Eur J Surg Oncol 30 (2004) 686-691
77. Kang J.C., Wanek L.A., Essner R., Faries M.B., Foshag L.J., and Morton D.L. Sentinel lymphadenectomy does not increase the incidence of in-transit-etastases in primary melanoma. J Clin Oncol 23 (2005) 4764-4770
78. Veronesi U., Paganelli G., and Viale G. A Randomized comparison of sentinel-node biopsy with routine axillary disection in breast cancer. N Engl J 349 (2003) 546-553
79. Schwartz G.F., Giuliano A.E., Veronesi U., and Concensus Conference Committee. Proceedings on the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, PA. Cancer 94 (2002) 2542-2551
80. Veronesi U., Galimbert V., Mariani L., et al. Sentinel node biopsy in breast cancer: early results in 953 pateints with negative sentinel node biopsy and no axillary dissection. Eur J Cancer 41 (2005) 231-237
81. Purushotham A.D., Upponi S., Klevesath M.B., et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23 (2005) 4312-4321
82. Rutgers E.J.Th. Guidelines to assure quality in breast cancer surgery. EJSO 31 (2005) 568-576
83. Levenback C., Coleman R.L., Burke T.W., et al. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol 83 (2001) 276-281
84. Kapteijn B.A.E., Nieweg O.E., Valdés Olmos R.A., et al. Reproducibility of lymphoscintigraphy for lymphatic mapping in cutaneous melanoma. J Nucl Med 37 (1997) 972-975
85. Radovanovic Z., Golubovic A., Plzak A., Stojiljkovic B., and Radovanovic D. Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer. Eur J Surg Oncol 30 (2004) 913-917
86. Morton D.L., Thompson J.F., Essner R., et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter selective lymphadenectomy trial group. Ann Surg 230 (1999) 453-463
87. Sanidas E.E., de Bree E., and Tsiftsis D.D. How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer?. Am J Surg 185 (2003) 202-210
88. Sanidas E.E., Daskalakis M., Sbyrakis N., and Tsiftsis D.D. Modifactions of the learning curve guidelines for breast cancer sentinel node biopsy. EJSO 31 (2005) 357-363
89. Ansink A.C., Sie-Go D.M.D.S., van der Velden J., et al. Identification of sentinel lymph nodes in vulvar carcinoma patients with the aid of a patent blue V injection. Cancer 86 (1999) 652-656
90. DeCicco C., Sideri M., Grana C., et al. Sentinel node biopsy in early vulvar cancer. Brit J Cancer 82 (2000) 295-299
91. de Hullu J.A., Hollema H., Piers D.A., et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 18 (2000) 2811-2816
92. Moore R.G., Depasquale S.E., Steinhoff M.M., et al. Sentinel node identification and the ability to detect metastastic tumor to inguinal lymph nodes in vulvar malignancies. Gynecol Oncol 89 (2003) 475-479
93. Puig-Tintoré L.M., Ordi J., Vidal-Sicart S., et al. Further data on the usefulness of sentinel lymph node identification and ultrastaging in vulvar squamous cell carcinoma. Gynecol Oncol 88 (2003) 29-34
94. DiSaia P.J., Creasman W.T., and Rich W.M. An alternative approach to early cancer of the vulva. Am J Obstet Gynecol 133 (1979) 825-830
95. Chu J., Tamimi H.K., and Figge D.C. Femoral node metastases with negative superficial inguinal nodes in early vulvar cancer. Am J Obstet Gynecol 140 (1981) 337-338
96. Levenback C., Burke T.W., Gershenson D.M., Morris M., Malpica A., and Ross M.I. Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol 84 (1994) 163-167
97. Levenback C., Burke T.W., Morris M., Malpica A., Lucas K.R., and Gershenson D.M. Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol 59 (1995) 216-220
98. DeCesare S.L., Fiorica J.V., Roberts W.S., et al. A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer. Gynecol Oncol 66 (1997) 425-428
99. De Hullu J.A., Doting M.H.E., Piers D.A., et al. Sentinel lymph node identification with Technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva. J Nucl Med 39 (1998) 1381-1385
100. De Cicco C., Sideri M., Bartolomei M., et al. Sentinel node detection by lymphoscintigraphy and gamma detecting probe in patients with vulvar cancer (abstract). J Nucl Med 38 (1997) 33P
101. Tavares M.G.M., Sapienza M.T., Galeb N.A., et al. The use of 99mTc-phytate for sentinel node mapping in melanoma, breast cancer and vulvar cancer: a study of 100 cases. Eur J Nucl Med 28 (2001) 1597-1604
102. Molpus K.L., Kelley M.C., and Johnson J.E. Sentinel lymph node detection and microstaging in vulvar carcinoma. J Reprod Med 46 (2001) 863-869
103. Makar A.P.H., Scheistroen M., van den Weyngaert D., and Tropé C.G. Surgical management of stage I and II vulvar cancer: the role of the sentinel node biopsy. Review of literature. Int J Gynecol Cancer 11 (2001) 255-262
104. Rodier J.F., Janser J.C., Routiot T., et al. Sentinel node biopsy in vulvar malignancies: a preliminary feasibility study. Oncol Rep 6 (1999) 1249-1252
105. Terada K.Y., Shimizu D.M., and Wong J.H. Sentinel node dissection and ultrastaging in squmaous cell cancer of the vulva. Gynecol Oncol 76 (2000) 40-44
106. Carcopino X., Hoevenaeghel G., Buttarelli M., et al. Feasibility and morbidity of sentinel lymph node detection in patients with vulvar carcinoma. Bull Cancer 92 (2005) 489-497
107. Sliutz G., Reinthaller A., Lantzsch T., et al. Lymphatic mapping of sentinel nodes in early vulvar cancer. Gynecol Oncol 84 (2002) 449-452
108. Louis-Sylvestre C., Evangelista E., Leonard F., Itti E., Meignan M., and Paniel B.J. Sentinel node localization should be interpreted wit caution in midline vulvar cancer. Gynecol Oncol 97 (2005) 151-154
109. Merisio C., Berretta R., Guladi M., et al. Radioguided sentinel lymph node detection in vulvar cancer. Int J Gynecol Cancer 15 (2005) 493-497
110. Fons G., ter Rahe B., Sloof G., de Hullu J., and van der Velden J. Failure in the detection of the sentinel lymph node with a combined technique of radioactive tracer and blue dye in a patient with cancer of the vulva and a single positive lymph node. Gynecol Oncol 92 (2004) 981-984
111. de Hullu J.A., Oonk M.H., Ansink A.C., Hollema H., Jager P.L., and van der Zee A.G.J. Pitfalls in the sentinel lymph node procedure in vulvar cancer. Gynecol Oncol 94 (2004) 10-15
112. Dhar K.K., and Woolas R.P. Lymphatic mapping and sentinel node biopsy in early vulvar cancer. BJOG 112 (2005) 696-702
113. Van Diest P.J., Torrenga H., Hollema H., Meijer S., Meijer C.J.L.M., and van der Zee AGJ. Ultra-staging of the sentinel node. In: Levenback C., et al. (Ed). Sentinel lymph node procedure (2004)
114. Hakam A., Nasir A., Raghuwanshi R., et al. Value of multilevel sectioning for improved detection of micrometastases in sentinel lymph nodes in invasive squamous cell carcinoma of the vulva. Anticancer Res 24 (2004) 1281-1286
115. Moore R.G., Granai C.O., Gajewski W., Gordinier M., and Steinhoff M.M. Pathologic evaluation of inguinal sentinel lymph nodes in vulvar cancer patients: a comparison of immunohistochemical staining versus ultrastaging with hematoxylin and eosin staining. Gynecol Oncol 91 (2003) 378-382
116. Oonk MHM, de Hullu JA, Ansink AC, et al. Chances for additional metastases in vulvar cancer pateints with a positive sentinel lymph node, Abstract ESGO, Istanbul, September 25-29, 2005.
117. Tjan-Heijnen V.C., Buit P., de Widt-Evert L.M., Ruers T.J., and Beex L.V. Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure. Breast Cancer Res Treat 70 (2001) 81-88
118. Blake P. Radiotherapy and chemoradiotherapy for carcinoma of the vulva. Best Pract Res Clin Obstet Gynaecol 17 (2003) 649-661
119. van der Velden J., and Ansink A. Primary groin irradiation versus primary groin surgery for early vulvar cancer (Cochrane Review). The Cochrane library, issue 1 (2002), Update Software, Oxford
120. Stehman F.B., Bundy B.N., Thomas G., et al. Groin dissection versus groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 24 (1992) 389-396
121. Manavi M., Berger A., Kucera E., Vavra N., and Kucera H. Does T1, N0-1 vulvar cancer treated by vulvectomy but not lymphadenectomy need inguinofemoral radiation?. Int J Radiat Oncol Biol Phys 38 (1997) 749-753
122. Perez C.A., Grigsby P.W., Chao C., et al. Irradiation in carcinoma of the vulva: factors affecting outcome. Int J Radiat Oncol Biol Phys 42 (1998) 335-344
123. Katz A., Eifel P.J., Jhingran A., and Levenback C.F. The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva. Int J Radiat Oncol Biol Phys 57 (2003) 409-418
124. Gordinier M.E., Malpica A., Burke T.W., et al. Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol 90 (2003) 625-628
125. Lataifeh I., Nascimento M.C., Nicklin L., Perrin L.C., Crandon A.J., and Obermair A. Patterns of recurrence and disease-free survival in advanced squamous cell carcinoma of the vulva. Gynecol Oncol 95 (2004) 701-705
126. Hoffman M.S. Squamous-cell carcinoma of the vulva: locally advanced disease. Best Pract Res Clin Obstet Gynaecol 17 (2003) 635-647
127. Flam M., Madhu J., Pajak T.F., et al. Role of radiotherapy in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14 (1996) 2527-2539
128. Eifel P.J., Morris M., Burke T.W., Levenback C., and Gershenson D.M. Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecol Oncol 59 (1995) 51-56
129. Pirtoli L., and Rottoli M.L. Results of radiation therapy for vulvar carcinoma. Acta Radiol Oncol 21 (1982) 45-48
130. Thomas G., Dembo A., DePetrillo J., Ackerman I., Bryson P., and Balogh J. Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecol Oncol 34 (1989) 263-267
131. Wahlen S.A., Slater J.D., Wagner R.J., et al. Concurrent radiation therapy and chemotherapy in the treatment of primary squamous cell carcinoma of the vulva. Cancer 75 (1995) 2289-2294
132. Russell A.H., Mesic J.B., Scudder S.A., et al. Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva. Gynecol Oncol 47 (1992) 14-20
133. Cunningham M.J., Goyer R.P., Gibbons S.K., Kredentser D.C., Malfetano J.H., and Keys H. Primary radiation, cisplatin, and 5-fluorouracil for advanced squamous carcinoma of the vulva. Gynecol Oncol 66 (1997) 258-261
134. Sebag-Montefiore D.J., McLean C., Arnott S.J., et al. Treatment of advanced carcinoma of the vulva with chemoradiotherapy-can exenterative surgery be avoided?. Int J Gynecol Cancer 4 (1994) 150-155
135. Moore D.H., Thomas G.M., Montana G.S., Saxer A., Gallup D.G., and Olt G. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys 42 (1998) 79-85
136. Lupi G., Raspagliesi F., Zucali R., et al. Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. A pilot study. Cancer 15 (1996) 1472-1478
137. Chao K.S., and Lin M. Lymphangiogram-assisted lymph node target delineation for patients with gynaecologic malignancies. Int J Radiat Oncol Biol Phys 15 (2002) 1147-1152
138. Bonner J.A., Giralt J., Harari P.M., et al. Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck: A phase III study of high dose radiation therapy with or without cetuximab. J Clin Oncol 22 (2004) 5507
139. Rodel C., Grabenbauer G.G., Kuhn R., et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 20 (2002) 3061-3071
140. Montana G.S., Thomas G.M., Moor D.H., et al. Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 48 (2000) 1007-1013
141. Pignon J.P., Bourhis J., Domenge C., and Desine L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 355 (2000) 949-955
142. Green J.A., Kirwan J.M., Tierney J.F., et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358 (2001) 781-786
143. Gerard J.P., Ayzac L., Hun D., et al. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long term results in 95 patients. Radiother Oncol 46 (1998) 249-256
144. Han S.C., Kim D.H., Higging S.A., et al. Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva. Int J Radiat Oncol Biol Phys 47 (2000) 1235-1244
145. Landoni F., Maneo A., Zanetta G., et al. Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar cancer. Gyn Oncol 61 (1996) 321-327
146. Lupi G., Raspagliesi F., Zucali R., et al. Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. Cancer 77 (1996) 142-148
147. Ryan D.P., Compton C.C., and Mayer R.J. Carcinoma of the anal canal. N Engl J Med 342 (2000) 792-800
148. Higgins R.V., Naumann W.R., Hall J.B., and Haake M. Concurrent carboplatin with pelvic radiation therapy in the primary treatment of cervix cancer. Gynecol Oncol 89 (2003) 499-503
149. Dubay R.A., Rose P.G., O'Malley D.M., et al. Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer. Gynecol Oncol 94 (2004) 121-124
150. Duenaz-Gonzales A., Cetina L., Sanchez B., et al. A phase I study of carboplatin concurrent with radiation in FIGO stage IIIB cervix uteri carcinoma. Int J Rad Oncol Biol Phys 5 (2003) 1361-1365
151. Maneo A., Landoni F., Cormio G., et al. Concurrent carboplatin/5-fluorouracil and radiotherapy for recurrent cervical carcinoma. Ann Oncol 10 (1999) 803-807
152. De Vos F.Y., Bos A.M., Gietema J.A., et al. Paclitaxel and carboplatin concurrent with radiotherapy for cervical cancer. Anticancer Res 24 (2004) 345-348
153. Porceddu S.V., Campbell B., Rischin D., et al. Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma. Int J Rad Oncol Biol Phys 60 (2004) 365-373
154. Homma A., Shirato H., Furuta Y., et al. Randomized Phase II trial of concomitant chemoradiotherapy using weekly carboplatin or daily low-dose cisplatin for squamous cell carcinoma of the head and neck. Cancer J 10 (2004) 326-332
155. Cutsem van E., Hoff P.M., Harper P., et al. Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses form two large, randomised, phase III trials. Br J Cancer 90 (2004) 1190-1197
156. Bellati F., Angioli R., Manci N., et al. Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases. Gynecol Oncol 96 (2005) 227-231